Ministry of Health and Population · Arab Republic of Egypt
Ministry of Health and Population100 Million Healthy Lives initiative
العربيةEnglishFrançais
InitiativesAll initiativesElderly Health Care Initiative"Our Children's Eyes, Our Future" InitiativeWomen's Health Support InitiativePremarital ScreeningCare for Children with Diabetes InitiativeMaternal and Fetal Health CareEarly Detection and Treatment of Cancer InitiativeInitiative for Early Detection and Treatment of Hearing Loss in NewbornsInitiative for Treating Children with Spinal Muscular AtrophyScreening and Treatment of Malnutrition among SchoolchildrenScreening and Treatment of Chronic Diseases and Early Detection of Kidney DiseaseEarly Detection of Genetic Diseases in NewbornsMental Health Support Initiative ("Your Health Is Happiness")Initiative for Mental Health Support and Early Intervention for Autism Spectrum DisordersThe Golden 1,000 Days Initiative for the Development of the Egyptian Family100 Days of Health
Health unitsAwarenessMedia centrePress releasesDocumentsFAQContact us
Press release

Health Ministry: Dr. Mohamed Hassany wins membership of the Governing Board of the African Medicines Agency

25 August 2025Ministry of Health and Population
Health Ministry: Dr. Mohamed Hassany wins membership of the Governing Board of the African Medicines Agency
Listening time ≈ 3 minutes
Speed

Health Ministry: Egypt's winning of this membership confirms Egyptian leadership on the African continent

—————————-

The Ministry of Health and Population announced that Dr. Mohamed Hassany, Assistant Minister of Health and Population for Public Health Projects and Initiatives, has won membership of the Governing Board of the African Medicines Agency.

This came during the Third Extraordinary Conference of the States Parties to the Treaty for the Establishment of the African Medicines Agency, held in the Ethiopian capital Addis Ababa, today, Wednesday, 24 April, and running for three days.

Dr. Hossam Abdel Ghaffar, the official spokesperson of the Ministry of Health and Population, explained that the opening session was attended by representatives of 30 African countries, and "Hassany" won

as the representative of the Community of Sahel-Saharan States, whose membership comprises 23 African and Arab countries.

"Abdel Ghaffar" pointed out that the Arab Republic of Egypt's winning of this seat confirms Egyptian leadership on the African continent and the pivotal role Egypt plays in pharmaceutical manufacturing, as well as the rapid development of the pharmaceutical regulatory system in Egypt, which is considered a global model.

"Abdel Ghaffar" added that this win crowns the joint work of the Ministry of Health and Population, the Ministry of Foreign Affairs and the Egyptian Drug Authority over the past two years, noting that in 2022 the Egyptian Drug Authority obtained maturity level 3 from the World Health Organization for the regulation of vaccines, which is the second highest level in the World Health Organization's classification of national regulatory authorities.

"Abdel Ghaffar" said that during the conference, the first ordinary meeting of the Agency's Governing Board was held after its composition was approved and its bureau elected. The meeting discussed mechanisms for operationalising the Agency's work and adopting its organisational structure, as well as the procedures for electing the Director General.

It is worth noting that the Arab Republic of Egypt is one of the first African countries to contribute to the establishment of the African Medicines Agency, and is working intensively with the countries party to the treaty to ensure the standard operationalisation of the Agency's work. The Agency aims to advance joint cooperation in the field of medicines and medical equipment among the countries of the African continent, improve the level of regulatory authorities in various countries, and support standard procedures for drug registration, which is reflected in the quality of medical products circulating on the African continent, limits the circulation of substandard or low-quality products, and raises countries' preparedness for any health emergencies threatening the peoples of the continent.